Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;

Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries J.M. Reyes; M.V. Gutierrez; H. Madariaga; W. Otero; R. Guzman; J. Izquierdo; M. Abello; P. Velez; D. Castillo; D. Ponce de Leon; T. Lukic; L. Amador;

Integrating different perspectives to define a concept of comprehensive remission in rheumatoid arthritis: The SUMAR project Alejandro Balsa; José Luis Andreu; Juan Carlos Hermosa-Hernán; Josefa León-Navarro; Jordi Nicolas Pico; José Javier Pérez Venegas; Susana Romero-Yuste; Raimon Sanmarti; Antonio Ignacio Torralba Gómez-Portillo; Juan Carlos Valenzuela-Gámez; Jordi Cohen;